Combined top-down approach with low-power thulium laser enucleation of prostate: evaluation of one-year functional outcomes

[1] Gee WF(1998)1997 American Urological Association Gallup survey: changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997 J Urol 160 1804-573

[2] Holtgrewe HL(2006)A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams:results at 2 years Eur Urol 50 569-297

[3] Blute ML(2016)The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: prevalence and Incident Rates Urol Clin North Am 43 289-954

[4] Wilson LC(2011)Clinical outcomes after combined therapy with dutasteride plus tamsulosin oreither monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial BJU Int 107 946-1613

[5] Gilling PJ(2016)Management of Benign Prostatic Hyperplasia Larger than 100 ml: simple Open Enucleation Versus Transurethral Laser Prostatectomy Curr Urol Rep. 17 44-262

[6] Fraundorfer MR(2013)BPH: hoLEP–a steep learning curve but better for patients Nat Rev Urol 10 66-80

[7] Egan KB(2012)Transurethral holmium laser enucleation versus transurethral resection of the prostate and simple open prostatectomy–which procedure is faster? J Urol 187 1608-120

[8] Roehrborn CG(2007)RevoLix vaporesection of the prostate: initial results of 54 patients with a one-year follow-up World J Urol 25 257-169

[9] Barkin J(2016)Thulium laser enucleation of the prostate is a safe and a highly effective modality for the treatment of benign prostatic hyperplasia - our experience of 236 patients Urol Ann 8 76-55

[10] Siami P(2015)Evaluation of the learning curve for thulium laser enucleation of the prostate with the aid of a simulator tool but without tutoring: comparison of two surgeons with different levels of endoscopic experience BMC Urol 9 49-1455

[1] Gee WF(1998)1997 American Urological Association Gallup survey: changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997 J Urol 160 1804-573

[2] Holtgrewe HL(2006)A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams:results at 2 years Eur Urol 50 569-297

[3] Blute ML(2016)The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: prevalence and Incident Rates Urol Clin North Am 43 289-954

[4] Wilson LC(2011)Clinical outcomes after combined therapy with dutasteride plus tamsulosin oreither monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial BJU Int 107 946-1613

[5] Gilling PJ(2016)Management of Benign Prostatic Hyperplasia Larger than 100 ml: simple Open Enucleation Versus Transurethral Laser Prostatectomy Curr Urol Rep. 17 44-262

[6] Fraundorfer MR(2013)BPH: hoLEP–a steep learning curve but better for patients Nat Rev Urol 10 66-80

[7] Egan KB(2012)Transurethral holmium laser enucleation versus transurethral resection of the prostate and simple open prostatectomy–which procedure is faster? J Urol 187 1608-120

[8] Roehrborn CG(2007)RevoLix vaporesection of the prostate: initial results of 54 patients with a one-year follow-up World J Urol 25 257-169

[9] Barkin J(2016)Thulium laser enucleation of the prostate is a safe and a highly effective modality for the treatment of benign prostatic hyperplasia - our experience of 236 patients Urol Ann 8 76-55

[10] Siami P(2015)Evaluation of the learning curve for thulium laser enucleation of the prostate with the aid of a simulator tool but without tutoring: comparison of two surgeons with different levels of endoscopic experience BMC Urol 9 49-1455